Reference
Du L, et al. Effective treatment with pd-1 antibody, chidamide, etoposide, and thalidomide (Pcet) for relapsed/ refractory natural killer/t-cell lymphoma: A report of three cases. OncoTargets and Therapy 13: 7189-7197, 2020. Available from: URL: http://doi.org/10.2147/OTT.S262039
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1821, 40 (2020). https://doi.org/10.1007/s40278-020-83160-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-83160-4